Literature DB >> 1356933

Gamma interferon modifies CD4+ subset expression in murine candidiasis.

L Romani1, E Cenci, A Mencacci, R Spaccapelo, U Grohmann, P Puccetti, F Bistoni.   

Abstract

A single injection of monoclonal antibody to gamma interferon administered in conjunction with a live Candida albicans yeast cell vaccine resulted in the detection of nonprotective Th2 rather than protective Th1 responses and altered the early expression of interleukin 4 and gamma interferon mRNA in CD4+ cells.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1356933      PMCID： PMC258253          DOI： 10.1128/iai.60.11.4950-4952.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  18 in total

Review 1.  Heterogeneity of cytokine secretion patterns and functions of helper T cells.

Authors:  T R Mosmann; R L Coffman
Journal:  Adv Immunol       Date:  1989       Impact factor: 3.543

Review 2.  Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo.

Authors:  R L Coffman; K Varkila; P Scott; R Chatelain
Journal:  Immunol Rev       Date:  1991-10       Impact factor: 12.988

Review 3.  Induction of Th1 and Th2 CD4+ subsets during murine Leishmania major infection.

Authors:  R M Locksley; F P Heinzel; B J Holaday; S S Mutha; S L Reiner; M D Sadick
Journal:  Res Immunol       Date:  1991-01

4.  Role of L3T4+ lymphocytes in protective immunity to systemic Candida albicans infection in mice.

Authors:  E Cenci; L Romani; A Vecchiarelli; P Puccetti; F Bistoni
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

5.  Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones.

Authors:  T F Gajewski; F W Fitch
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

6.  Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance.

Authors:  L Romani; S Mocci; C Bietta; L Lanfaloni; P Puccetti; F Bistoni
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

7.  Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.

Authors:  M Belosevic; D S Finbloom; P H Van Der Meide; M V Slayter; C A Nacy
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

8.  T cell subsets and IFN-gamma production in resistance to systemic candidosis in immunized mice.

Authors:  E Cenci; L Romani; A Vecchiarelli; P Puccetti; F Bistoni
Journal:  J Immunol       Date:  1990-06-01       Impact factor: 5.422

9.  IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.

Authors:  P Scott
Journal:  J Immunol       Date:  1991-11-01       Impact factor: 5.422

10.  Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis.

Authors:  L Romani; A Mencacci; U Grohmann; S Mocci; P Mosci; P Puccetti; F Bistoni
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307
View more
  21 in total

1.  Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.

Authors:  J Brieland; D Essig; C Jackson; D Frank; D Loebenberg; F Menzel; B Arnold; B DiDomenico; R Hare
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  Immunization with the Candida albicans membrane fraction and in combination with fluconazole protects against systemic fungal infections.

Authors:  S Mizutani; M Endo; T Ino-Ue; M Kurasawa; Y Uno; H Saito; I Kato; K Takesako
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  Cellular and cytokine correlates of mucosal protection in murine model of oral candidiasis.

Authors:  S Elahi; G Pang; R Clancy; R B Ashman
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

4.  CD4+ T-helper-cell responses in mice with low-level Candida albicans infection.

Authors:  A Mencacci; R Spaccapelo; G Del Sero; K H Enssle; A Cassone; F Bistoni; L Romani
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

5.  Candida albicans is phagocytosed, killed, and processed for antigen presentation by human dendritic cells.

Authors:  S L Newman; A Holly
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

6.  Candida albicans suppresses nitric oxide (NO) production by interferon-gamma (IFN-gamma) and lipopolysaccharide (LPS)-stimulated murine peritoneal macrophages.

Authors:  T Chinen; M H Qureshi; Y Koguchi; K Kawakami
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

7.  A mannoprotein constituent of Candida albicans that elicits different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice.

Authors:  A Mencacci; A Torosantucci; R Spaccapelo; L Romani; F Bistoni; A Cassone
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

Review 8.  IL-12 and related cytokines: function and regulatory implications in Candida albicans infection.

Authors:  Robert B Ashman; Dipti Vijayan; Christine A Wells
Journal:  Clin Dev Immunol       Date:  2010-11-01

9.  Natural killer cells do not play a dominant role in CD4+ subset differentiation in Candida albicans-infected mice.

Authors:  L Romani; A Mencacci; E Cenci; R Spaccapelo; E Schiaffella; L Tonnetti; P Puccetti; F Bistoni
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

10.  Normal host defense during systemic candidiasis in mannose receptor-deficient mice.

Authors:  Sena J Lee; Nai-Ying Zheng; Monica Clavijo; Michel C Nussenzweig
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.